McDonnell Boehnen Hulbert & Berghoff LLP partner Dr. Kevin Noonan is quoted in an August 25, 2016 edition of BioWorld.com in an article entitled, “Tying drug price to exclusivity is just a simplistic beat in a complex cadence.” The drum beat over high drug prices continues its steady roll, accentuated by predictable cymbal crashes calling for a rethink of government policies that create lengthy monopolies for pricy drugs. View the article